-
Molecular Insight (MIPI) Gets Third Extension for Waiver Agreement with Bondholders
-
Molecular Insight Pharma (MIPI) Receives Extension with Bondholders; Restructuring Decision to Continue
-
Molecular Insight (MIPI) Reports Q4 Loss of $0.52; to Breach Min. Liquidity Requirements if Unable to Raise Additional Capital
-
Unusual 11 Mid-Day Movers 6/17: SVNT, MIPI, MEA, ALVR Higher; STSI, AHT, ARM, AXL Lower

